THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Instead of consuming opiates or going for surgery, civilians, veterans, and active duty soldiers can use ZetrOz’s wearable therapeutic ultrasound—sam—for pain management and physical therapy
Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD
Share this Article: Tweet |
Company
ZetrOz
Management
George K. Lewis, President & CEO
Description
ZetrOZ Systems develops wearable bioelectronic devices for the delivery of Sustained Acoustic Medicine. Built on their proprietary miniaturized ultrasound platform designed for the treatment of acute and chronic musculoskeletal conditions, sam devices are clinically proven to enhance tissue recovery, accelerate the body’s natural healing processes, and relieve pain. sam Sport delivers sustained acoustic medicine for the treatment of select medical conditions such as the relief of pain, the relief of muscle spasm, the treatment of joint contracture and the local increase in circulation while sam Pro offers the same benefit to commercial patients
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
However, if you would like to share the information in this article, you may use the link below:
ultrasound.medicaltechoutlook.com/vendor/zetroz-wearable-therapeutic-ultrasound-cid-403-mid-42.html
TRUMBULL - ZetrOZ Systems presented the benefits of its sam X1 wireless wearable device at the College Athletic Trainers' Society (CATS) symposium May 18-20, 2023, at The Orleans Hotel and Casino in Las Vegas. As displayed to sports physicians and trainers in attendance, sam X1 can accelerate soft-tissue repair and deliver sustained acoustic medicine that has been approved for a convenient home-use prescription.
The Society was founded to provide and manage healthcare for the intercollegiate student-athlete through athletic trainers and healthcare professionals. At the symposium, ZetrOZ focused on how sam ultrasound treatment can help athletes return to form faster and how patients have reported significant pain reduction in the past.
ZetrOZ demonstrated how the sam unit, a long-duration low-intensity soft-tissue repair ultrasound device, can help patients supercharge their injury healing process, providing healthcare professionals with a proven method of accelerating and enhancing soft tissue healing.
"Attending CATS each year is a great opportunity to share the latest medical innovations with the leading front-line healthcare providers in sports medicine," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "This year we had the opportunity to share the sam® X1 wireless device, which is advancing the sam® platform and accelerating return to play for common overuse injuries. We are proud to be partners with the CATS organization."
The sam® X1 and 2.0 units soft tissue treatment devices are the only FDA-cleared, drug-free, and non-invasive wearable ultrasound units of their kind approved for daily home use.
Sustained acoustic medicine is a daily ultrasound treatment that can reduce the need for pain medication and surgery. Using mechanobiological technology, sam® increases blood vessel diameters to improve blood flow, increasing oxygenated hemoglobin at the site, and removing cytokine enzymes and cellular waste for rapid healing and reduced pain.
With support from the National Science Foundation, the National Institutes of Health, and other reputed health organizations, ZetrOZ has researched and developed sustained acoustic medicine technology into a powerful, non-invasive alternative to invasive surgery and potentially addictive pain medication. It has been clinically proven by over 30 studies to reduce joint pain, treat pain and improve function.